159 related articles for article (PubMed ID: 36865325)
1. Glioma genetic profiles associated with electrophysiologic hyperexcitability.
Tobochnik S; Dorotan MKC; Ghosh HS; Lapinskas E; Vogelzang J; Reardon DA; Ligon KL; Bi WL; Smirnakis SM; Lee JW
medRxiv; 2023 Feb; ():. PubMed ID: 36865325
[TBL] [Abstract][Full Text] [Related]
2. Glioma genetic profiles associated with electrophysiologic hyperexcitability.
Tobochnik S; Dorotan MKC; Ghosh HS; Lapinskas E; Vogelzang J; Reardon DA; Ligon KL; Bi WL; Smirnakis SM; Lee JW
Neuro Oncol; 2024 Feb; 26(2):323-334. PubMed ID: 37713468
[TBL] [Abstract][Full Text] [Related]
3. Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma.
Tobochnik S; Lapinskas E; Vogelzang J; Ligon KL; Lee JW
J Neurooncol; 2022 Aug; 159(1):211-218. PubMed ID: 35715666
[TBL] [Abstract][Full Text] [Related]
4. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
5. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Eckel-Passow JE; Lachance DH; Molinaro AM; Walsh KM; Decker PA; Sicotte H; Pekmezci M; Rice T; Kosel ML; Smirnov IV; Sarkar G; Caron AA; Kollmeyer TM; Praska CE; Chada AR; Halder C; Hansen HM; McCoy LS; Bracci PM; Marshall R; Zheng S; Reis GF; Pico AR; O'Neill BP; Buckner JC; Giannini C; Huse JT; Perry A; Tihan T; Berger MS; Chang SM; Prados MD; Wiemels J; Wiencke JK; Wrensch MR; Jenkins RB
N Engl J Med; 2015 Jun; 372(26):2499-508. PubMed ID: 26061753
[TBL] [Abstract][Full Text] [Related]
6. Human glioma cells induce hyperexcitability in cortical networks.
Campbell SL; Buckingham SC; Sontheimer H
Epilepsia; 2012 Aug; 53(8):1360-70. PubMed ID: 22709330
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
Shee K; Chambers M; Hughes EG; Almiron DA; Deharvengt SJ; Green D; Lefferts JA; Andrew AS; Hickey WF; Tsongalis GJ
J Neurooncol; 2020 Jul; 148(3):473-480. PubMed ID: 32583303
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML
Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405
[TBL] [Abstract][Full Text] [Related]
9. Effect of PIK3CA variants on glioma-related epilepsy and response to treatment.
Tobochnik S; Pisano W; Lapinskas E; Ligon KL; Lee JW
Epilepsy Res; 2021 Sep; 175():106681. PubMed ID: 34102393
[TBL] [Abstract][Full Text] [Related]
10. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
11. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients.
Claassen J; Mayer SA; Kowalski RG; Emerson RG; Hirsch LJ
Neurology; 2004 May; 62(10):1743-8. PubMed ID: 15159471
[TBL] [Abstract][Full Text] [Related]
12. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.
Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M
Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320
[TBL] [Abstract][Full Text] [Related]
13. Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
MacKenzie G; O'Toole KK; Moss SJ; Maguire J
Epilepsy Res; 2016 Oct; 126():185-96. PubMed ID: 27513374
[TBL] [Abstract][Full Text] [Related]
14. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: An analysis of 442 glioma patients from China.
Shen S; Bai Y; Zhang B; Liu T; Yu X; Feng S
Epilepsy Res; 2020 Oct; 166():106430. PubMed ID: 32712511
[TBL] [Abstract][Full Text] [Related]
15. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.
Neal A; Kwan P; O'Brien TJ; Buckland ME; Gonzales M; Morokoff A
Epilepsy Behav; 2018 Jan; 78():30-36. PubMed ID: 29172136
[TBL] [Abstract][Full Text] [Related]
16. Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
Wang YH; Huang TL; Chen X; Yu SX; Li W; Chen T; Li Y; Kuang YQ; Shu HF
J Neuropathol Exp Neurol; 2021 Jan; 80(2):137-149. PubMed ID: 33382873
[TBL] [Abstract][Full Text] [Related]
17. Impact of seizures and antiseizure medication on survival in patients with glioma.
Kumar TS; Afnan WM; Chan CY; Audrey C; Fong SL; Rajandram R; Lim KS; Narayanan V
J Neurooncol; 2022 Sep; 159(3):657-664. PubMed ID: 36036318
[TBL] [Abstract][Full Text] [Related]
18. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH
Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737
[TBL] [Abstract][Full Text] [Related]
19. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.
Erson-Omay EZ; Çağlayan AO; Schultz N; Weinhold N; Omay SB; Özduman K; Köksal Y; Li J; Serin Harmancı A; Clark V; Carrión-Grant G; Baranoski J; Çağlar C; Barak T; Coşkun S; Baran B; Köse D; Sun J; Bakırcıoğlu M; Moliterno Günel J; Pamir MN; Mishra-Gorur K; Bilguvar K; Yasuno K; Vortmeyer A; Huttner AJ; Sander C; Günel M
Neuro Oncol; 2015 Oct; 17(10):1356-64. PubMed ID: 25740784
[TBL] [Abstract][Full Text] [Related]
20. Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.
Jonsson P; Lin AL; Young RJ; DiStefano NM; Hyman DM; Li BT; Berger MF; Zehir A; Ladanyi M; Solit DB; Arnold AG; Stadler ZK; Mandelker D; Goldberg ME; Chmielecki J; Pourmaleki M; Ogilvie SQ; Chavan SS; McKeown AT; Manne M; Hyde A; Beal K; Yang TJ; Nolan CP; Pentsova E; Omuro A; Gavrilovic IT; Kaley TJ; Diamond EL; Stone JB; Grommes C; Boire A; Daras M; Piotrowski AF; Miller AM; Gutin PH; Chan TA; Tabar VS; Brennan CW; Rosenblum M; DeAngelis LM; Mellinghoff IK; Taylor BS
Clin Cancer Res; 2019 Sep; 25(18):5537-5547. PubMed ID: 31263031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]